Indiana Oncology/Hematology Consultants

Indianapolis, Indiana 46237

0 studies enrolling now · 10 studies all time

What they study most

Acute Myeloid Leukemia, Adenocarcinoma, Chronic Lymphocytic Leukemia, Chronic Myelomonocytic Leukemia, Lung Cancer, Malignant Metastatic Melanoma, Melanoma, Myelodysplastic Syndrome, Myeloproliferative Disorders, Neoplasm Metastasis, Non Small Cell Lung Carcinoma, Pancreatic Cancer

Studies at this site

• Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer — Completed
• A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies — Completed
• Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL) — Completed
• A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome — Completed
• 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer — Completed
• Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia — Stopped early
• Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma — Completed
• Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma — Completed
• Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas — Stopped early
• Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia. — Status unconfirmed